Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes

Table 2 Risk factors for nonalcoholic fatty liver disease

Variables	β	SE	P value	OR	95%CI
Total patients with T2DM
logBMI	16.33	2.24	0.00	1.238 × 107	154915.06-9.897 × 108
logWC	5.57	2.57	0.03	261.45	1.69-40422.03
logTG	2.05	0.34	0.00	7.79	3.99-15.19
FBG	0.079	0.03	0.01	1.08	1.02-1.15
DBP	0.03	0.01	0.00	1.03	1.01-1.05
SBP	0.03	0.01	0.00	1.03	1.02-1.04
Duration of diabetes	-0.05	0.01	0.00	0.96	0.93-0.98
DR	-0.035	0.17	0.04	0.71	0.51-0.99
DPN	-0.38	0.17	0.03	0.69	0.50-0.95
DN	-1.15	0.19	0.00	0.32	0.22-0.46
logHDL	-1.76	0.84	0.04	0.17	0.03-0.89
Male patients with T2DM
logBMI	24.53	3.37	0.00	4.52 × 1010	6.128 × 107-3.334 × 1013
logTG	3.63	0.62	0.00	37.88	11.34-126.61
DBP	0.08	0.02	0.00	1.09	1.05-1.12
Duration of diabetes	-0.07	0.02	0.00	0.94	0.90-0.98
logHDL	-4.92	1.72	0.00	0.01	0.00-0.21
Female patients with T2DM
logBMI	16.91	2.05	0.00	2.21 × 107	395927.04-1.23 × 109
logTG	1.25	0.42	0.00	3.48	1.54-7.90
FBG	0.2	0.04	0.00	1.22	1.13-1.31
SBP	0.04	0.01	0.00	1.04	1.03-1.05
Duration of diabetes	-0.04	0.01	0.00	0.96	0.93-0.98
DPN	-0.44	0.21	0.04	0.65	0.43-0.98
DR	-0.49	0.21	0.02	0.61	0.41-0.93
DN	-1.23	0.23	0.00	0.29	0.19-0.46

T2DM: Type 2 diabetes mellitus; WC: Waist circumference; TG: Triglyceride; BMI: Body mass index; FBG: Fasting blood glucose; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; HDL: High-density lipoprotein; DR: Diabetic retinopathy; DPN: Diabetic peripheral neuropathy; DN: Diabetic nephropathy.